These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 4398593)
1. Selective effects of heterospecific antilymphocyte sera on graft and host components in graft-versus-host reactions. Brune K; Floersheim GL Agents Actions; 1970 Mar; 1(3):112-4. PubMed ID: 4398593 [No Abstract] [Full Text] [Related]
2. Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor. Boak JL; Wilson RE Clin Exp Immunol; 1968 Oct; 3(8):795-800. PubMed ID: 5718503 [TBL] [Abstract][Full Text] [Related]
6. [Mechanism of a heterologous, cutaneous Graft-Versus-Host reaction in mice]. Brune K Z Gesamte Exp Med Einschl Exp Chir; 1969 Sep; 151(1):74-88. PubMed ID: 4391808 [No Abstract] [Full Text] [Related]
7. Comparison between the effect of rabbit anti-rat lymphocyte sera raised by thymus, thoracic duct, and spleen lymphocytes on second-set tumor allograft in the rat. Girardet RE; Glass N; Patti J; Gardner B J Surg Res; 1971 Sep; 11(9):433-40. PubMed ID: 5094737 [No Abstract] [Full Text] [Related]
8. Aspects in production of antilymphocyte sera. Pichlmayr R Fed Proc; 1970; 29(1):111-3. PubMed ID: 4983810 [No Abstract] [Full Text] [Related]
9. Modification of the second set reaction by antilymphocytic serum. Boak JL; Draper V; House AK; Pattisson PH Br J Surg; 1971 Apr; 58(4):300-1. PubMed ID: 4396709 [No Abstract] [Full Text] [Related]
10. Studies of thoracic duct lymphocytes of mice. II. A quantitative comparison of the capacity of thoracic duct lymphocytes and other lymphoid cells to induce graft-versus-host reactions. Cantor H; Mandel MA; Asofsky R J Immunol; 1970 Feb; 104(2):409-13. PubMed ID: 4391693 [No Abstract] [Full Text] [Related]
11. Treatment and pretreatment of graft-versus-host reaction by antilymphocyte serum. Haskovcová H; Nouza K Folia Biol (Praha); 1970; 16(6):397-406. PubMed ID: 4395162 [No Abstract] [Full Text] [Related]
12. [Specificity of the anti-lymphocyte serum]. Nomoto K Saishin Igaku; 1969 Jul; 24(7):1494-9. PubMed ID: 4390975 [No Abstract] [Full Text] [Related]
13. [The importance of antilymphocyte serum in immunosuppression]. Pichlmayr R Langenbecks Arch Chir; 1968; 322():485-95. PubMed ID: 4394915 [No Abstract] [Full Text] [Related]
14. Time-dependence of ALS effects on immunological and haematopoietic activities in mice. Nouza K; Haskovcová H; Nĕmec M Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318 [No Abstract] [Full Text] [Related]
15. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies]. Brune K Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853 [No Abstract] [Full Text] [Related]
16. Anatomical distribution of T and B lymphocytes in the rat. Development of lymphocyte-specific antisera. Goldschneider I; McGregor DD J Exp Med; 1973 Dec; 138(6):1443-65. PubMed ID: 4586980 [TBL] [Abstract][Full Text] [Related]
17. Time course and mechanism by which alloantiserum raised against thoracic duct lymphocytes abrogates runt disease in the rat. Clancy J; Rieke WO Transplantation; 1973 Jan; 15(1):59-69. PubMed ID: 4145727 [No Abstract] [Full Text] [Related]
18. [Suppression of primary and secondary immune response by antilymphocyte serum, shown by antigen-specific proliferation activity in graft-vs-host model]. Baumann P; Thierfelder S Blut; 1974 Jan; 28(1):51-5. PubMed ID: 4149351 [No Abstract] [Full Text] [Related]
19. Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity. Nehlsen SL Clin Exp Immunol; 1971 Jul; 9(1):63-77. PubMed ID: 4397709 [TBL] [Abstract][Full Text] [Related]